Protect from light: B12 in particular is photosensitive
These conditions may influence whether combination therapy is appropriate
As your body adapts to the medication over weeks and months, gastrointestinal side effects generally improve
Announcing the STEER study results at the European Society of Cardiology (ESC) Congress 2025 in Spain, the weight-loss giant presented that, compared with Tirzepatide, Wegovy showed a 57 per cent greater risk reduction for heart attack, cardiovascular-related death in obese patients without diabetes. Under the observational real-world study, the drugmaker recorded that, among patients treated with Wegovy around 15 (0.1 per cent of the total pool) events of heart attack, stroke and cardiovascular-related deaths were reported whereas in Tirzepatide 39 events were recorded (0.4 per cent of the total pool)
Dosing errors occur more frequently with compounded tirzepatide because patients often receive unclear measurement instructions or misunderstand concentration differences between formulations
The constant mental chatter about food, what many call food noise, often decreases dramatically